Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
Elsevier,
Artificial Intelligence, Machine Learning, and Mental Health in Pandemics: A Computational Approach, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.
Epigenetics of Stress and Stress Disorders - Chapter 6 Depression management and pharmacoepigenetics
Epigenetics of Stress and Stress Disorders, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining Pharmacoepigenetics as an emerging field and the relation of epigenetic mechanisms to treatment response to inform treatment selection.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining race, ethnicity, culture, national origin, color, gender, gender identity, sexual orientation, class, age, marital status, political belief, religion, geographic region, mental or physical disability, and historical or current experiences with the dominant culture to fully understand human behavior.
Elsevier,
iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the types of human podiatry disabilities and correction methods using traditional, 3DP technology and its challenges.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing diagnostic occlusion and investigative occlusion for better patient outcomes..
